Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
222 hedge funds and large institutions have $948M invested in Immunogen Inc in 2022 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 73 increasing their positions, 71 reducing their positions, and 23 closing their positions.
379% more call options, than puts
Call options by funds: $5.71M | Put options by funds: $1.19M
26% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 23
7% more capital invested
Capital invested by funds: $882M → $948M (+$65.9M)
3% more funds holding
Funds holding: 216 → 222 (+6)
3% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 71
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$32.7M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$12.7M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$9.48M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$5.23M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$4.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$19.4M |
| 2 |
State Street
Boston,
Massachusetts
|
-$19M |
| 3 |
Millennium Management
New York
|
-$17M |
| 4 |
DM
Deerfield Management
New York
|
-$6.75M |
| 5 |
Morgan Stanley
New York
|
-$3.91M |
IMGN Hedge Fund Activity: Q3 2022 in Review
222 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2022, worth a combined $948M — up 7.5% from $882M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new IMGN positions and 23 closed out — a net gain of 6 holders — while 73 added to existing stakes and 71 trimmed.
The largest buyer was Jennison Associates, opening a new position worth an estimated $32.7M. The largest seller was Adage Capital Partners, cutting an estimated $19.4M.
- 222 institutional investors held Immunogen Inc (IMGN) as of Q3 2022, up from 216 in Q2 2022.
- Funds reported $948M of Immunogen Inc stock for Q3 2022, up 7.5% quarter-over-quarter.
- 29 funds opened new Immunogen Inc positions in Q3 2022 and 23 closed out, a net change of +6 holders.
- The largest Immunogen Inc buyer in Q3 2022 was Jennison Associates, an estimated $32.7M added.
- The largest Immunogen Inc seller in Q3 2022 was Adage Capital Partners, an estimated $19.4M sold.
Based on aggregated 13F filings for Q3 2022.